<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00103350</url>
  </required_header>
  <id_info>
    <org_study_id>TG001-03</org_study_id>
    <nct_id>NCT00103350</nct_id>
    <nct_alias>NCT00104208</nct_alias>
  </id_info>
  <brief_title>Safety of TG100-115 for Heart Attack Treated With Angioplasty</brief_title>
  <official_title>A Phase 1-2, Multicenter, Randomized, Double-Blind, Placebo Controlled, Prospective Study to Evaluate the Safety and Potential Efficacy of Single, Increasing Doses of TG100-115 in Subjects Undergoing Percutaneous Coronary Intervention for Acute Anterior ST Elevation Myocardial Infarction</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>TargeGen</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>TargeGen</source>
  <brief_summary>
    <textblock>
      TG100-115 is able to reduce the size of heart attacks in pre-clinical models. The hypothesis
      of this study is that TG100-115 can be given safely to patients who suffer a heart attack and
      undergo angioplasty to restore blood flow. We will also evaluate whether TG100-115 reduces
      heart muscle damage.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>January 2005</start_date>
  <completion_date type="Actual">January 2008</completion_date>
  <primary_completion_date type="Actual">December 2006</primary_completion_date>
  <phase>Phase 1/Phase 2</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Safety and pharmacokinetics of TG100-115</measure>
  </primary_outcome>
  <secondary_outcome>
    <measure>Impact of TG100-115 on infarct size</measure>
  </secondary_outcome>
  <enrollment>100</enrollment>
  <condition>Myocardial Infarction</condition>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>TG100-115</intervention_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Age 18-80 yrs

          -  ECG patterns consistent with an acute anterior myocardial infarction with ST segment
             elevation of 2mm in two contiguous ECG leads among leads V1-V4.

          -  Have prolonged, continuous (lasting at least 20 mins) signs and symptoms of myocardial
             ischemia not eliminated with nitrates.

          -  Intent to proceed to primary PCI within 6 hours of chest pain onset

          -  Sign an informed consent form and be willing to attend follow-up visits for safety and
             other study assessments.

        Exclusion Criteria:

          -  Female of childbearing potential.

          -  History of previous myocardial infarction.

          -  History of congestive heart failure.

          -  Requirement for a cardiac pacemaker or defibrillator.

          -  Cardiogenic shock.

          -  Patients previously treated with thrombolytic therapy.

          -  Myocardial ischemia precipitated by a condition other than atherosclerotic coronary
             artery disease.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>David Holmes, MD</name>
      <address>
        <city>Rochester</city>
        <state>Minnesota</state>
        <zip>55905</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>May 2008</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>February 7, 2005</study_first_submitted>
  <study_first_submitted_qc>February 7, 2005</study_first_submitted_qc>
  <study_first_posted type="Estimate">February 8, 2005</study_first_posted>
  <last_update_submitted>May 16, 2008</last_update_submitted>
  <last_update_submitted_qc>May 16, 2008</last_update_submitted_qc>
  <last_update_posted type="Estimate">May 20, 2008</last_update_posted>
  <keyword>myocardial infarction</keyword>
  <keyword>infarct size</keyword>
  <keyword>angioplasty</keyword>
  <keyword>percutaneous coronary intervention</keyword>
  <keyword>Acute Myocardial Infarction</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Infarction</mesh_term>
    <mesh_term>Myocardial Infarction</mesh_term>
    <mesh_term>ST Elevation Myocardial Infarction</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

